Abstract
Nanomedicine has shown good potentials for cancer diagnosis and treatment since the last decades. Among the various nanoparticles exploited for cancer management so far, gold nanomaterials (e.g., spherical gold nanoparticles and gold nanorods) were extensively investigated due to their unique chemo-physical properties. We herein summarize the emerging application and discuss the challenges of using gold nanomaterials for therapy of metastatic cancer.
Similar content being viewed by others
References
Mehlen P, Puisieux A. Nat Rev Cancer, 2006, 6: 449–458
Algaba F, Akaza H, Lopez-Beltran A, Martignoni G, Moch H, Montironi R, Reuter V. Eur Urol, 2011, 60: 634–643
Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. Histopathology, 2013, 62: 367–386
Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Nature, 2007, 449: 557–563
Braun S, Kentenich C, Janni W, Hepp F, de Waal J, Willgeroth F, Sommer H, Pantel K. J Clin Oncol, 2000, 18: 80–86
Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Nat Rev Cancer, 2012, 12: 39–50
Ferrari M. Nat Rev Cancer, 2005, 5: 161–171
Cheng R, Feng F, Meng FH, Deng C, Feijen J, Zhong Z. J Control Release, 2011, 152: 2–12
Bae Y, Fukushima S, Harada A, Kataoka K. Angew Chem Int Ed, 2003, 42: 4640–4643
Rao J, Khan A. J Am Chem Soc, 2013, 135: 14056–14059
Yan B, Boyer JC, Branda NR, Zhao Y. J Am Chem Soc, 2011, 133: 19714–19717
Lecommandoux SB, Sandre O, Checot F, Rodriguez-Hernandez JR. Adv Mater, 2005, 17: 712–718
Niu D, Wang X, Li Y, Zheng Y, Zheng Y, Li F, Chen H, Gu J, Zhao W, Shi J. Adv Mater, 2013, 25: 2686–2692
Wei H, Cheng SX, Zhang XZ, Zhuo RX. Prog Polym Sci, 2009, 34: 893–910
Gormley AJ, Larson N, Sadekar S, Robinson R, Ray A, Ghandehari H. Nano Today, 2012, 7: 158–167
Jang H, Kim YK, Huh H, Min DH. ACS Nano, 2014, 8: 467–475
Berardi R, Maccaroni E, Mandolesi A, Mantello G, Onofri A, Biscotti T, Pierantoni C, Siquini W, Marmorale C, Guerrieri M, Bearzi I, Cascinu S. Diges Liver Dis, 2012, 44: 617–622
Llevot A, Astruc D. Chem Soc Rev, 2012, 41: 242–257
Shukla R, Chanda N, Zambre A, Upendran A, Katti K, Kulkarni RR, Nune SK, Casteel SW, Smith CJ, Vimal J, Boote E, Robertson JD, Kan P, Engelbrecht H, Watkinson LD, Carmack TL, Lever JR, Cutler CS, Caldwell C, Kannan R, Katti KV. Proc Natl Acad Sci USA, 2012, 109: 12426–12431
Perez-Juste J, Pastoriza-Santos I, Liz-Marzan LM, Mulvaney P. Coordin Chem Rev, 2005, 249: 1870–1901
Sardar R, Heap TB, Shumaker-Parry JS. J Am Chem Soc, 2007, 129: 5356–5357
Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ. J Am Chem Soc, 2009, 131: 14652–14653
Kim D, Jeong YY, Jon S. ACS Nano, 2010, 4: 3689–3696
Kennedy L, Bickford L, Lewinski N, Coughlin A, Hu Y, Day E, West J, Drezek R. Small, 2011, 7: 169–183
Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. ACS Nano, 2009, 3: 80–86
Salem AK, Searson PC, Leong KW. Nat Mater, 2003, 2: 668–671
Chanda N, Shukla R, Katti KV, Kannan R. Nano Lett, 2009, 9: 1798–1805
Bonoiu AC, Mahajan SD, Ding H, Yong KT, Kumar R, Hu R, Bergey EJ, Schwartz SA, Prasad PN. Proc Natl Acad Sci USA, 2009, 106: 5546–5550
Bhattacharya R, Mukherjee P. Adv Drug Deliver Rev, 2009, 60: 1289–1306
Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P. Nanomed Nanotech, 2011, 7: 580–587
Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P. Proc Natl Acad Sci USA, 2013, 110: 6700–6705
Zhou T, Yu MF, Zhang B, Wang L, Wu X, Zhou H, Du Y, Hao J, Tu Y, Chen C, Wei T. Adv Funct Mater, 2014, 24: 6922–6932
Feng B, Xu Z, Zhou F, Yu H, Sun Q, Wang D, Tang Z, Yu H, Yin Q, Zhang Z, Li Y. Nanoscale, 2015, 7: 14854–14864
Wang D, Xu Z, Yu H, Chen X, Feng B, Cui Z, Lin B, Yin Q, Zhang Z, Chen C, Wang J, Zhang W, Li Y. Biomaterials, 2014, 35: 8374–8384
Chaffer CL, Weinberg RA. Science, 2011, 331: 1559–1564
Sethi N, Kang Y. Nat Rev Cancer, 2011, 11: 735–748
Fidler IJ. Nat Rev Cancer, 2005, 3: 453–458
Carmeliet P. Nature, 2005, 438: 932–936
Al-Mehdi AB, Tozawa K, Fisher AB. Nat Med, 2000, 6: 100–102
Ferrara N, Gerber HP, LeCouter J. Nat Med, 2003, 9: 669–676
Lee JH, Canny MD,De Erkenez A. Proc Natl Acad Sci USA, 2005, 102: 18902–18907
Arvizo R, Rana S, Miranda O, Bhattacharya R, Rotello V, Mukherjee P. Nanomedicine, 2011, 7: 580–587
Bhattacharya R, Mukherjee P, Xiong Z. Nano Lett, 2004, 4: 242479–242481
Ferrara N, Kerbel RS. Nature, 2005, 438: 967–974
Ferrara N, Hillan KJ, Novotny W. Biochem Bioph Res, 2005, 333: 328–335
Lauffenburger DA, Horwitz AF. Cell, 1996, 84: 359–369
Machesky LM. FEBS Lett, 2008, 582: 2102–2111
McCarthy JB, Basara ML, Palm SL. Cancer Metast Rev, 1985, 4: 125–152
Friedl P, Wolf K. Nat Rev Cancer, 2003, 3: 362–374
Geschwind JF, Ko YH, Torbenson MS. Cancer Res, 2002, 62: 3909–3913
Chu KF, Dupuy DE. Nat Rev Cancer, 2014, 14: 199–208
Choi WI, Kim JY, Kang C. ACS Nano, 2011, 5: 1995–2003
Hauck TS, Jennings TL, Yatsenko T. Adv Mater, 2008, 20: 3832–3838
Li JL, Day D, Gu M. Adv Mater, 2008, 20: 3866–3871
Zhang Z, Wang J, Nie X, Wen T, Ji Y, Wu X, Zhao Y, Chen C. J Am Chem Soc, 2014, 136: 7317–7326
Yang J, Mani SA, Donaher JL. Cell, 2004, 117: 927–939
Tsai JH, Donaher JL, Murphy DA. Cancer Cell, 2012, 22: 725–736
Huber MA, Azoitei N, Baumann B. J Clin Invest, 2004, 114: 569–581
Wu Y, Deng J, Rychahou PG. Cancer Cell, 2009, 15: 416–428
Deryugina EI, Quigley JP. Cancer Metast Rev, 2006, 25: 9–34
Ansieau S, Bastid J, Doreau A. Cancer Cell, 2008, 14: 79–89
Mojsilovic SS, Santibanez JF. Cell Bio Int, 2015, 39: 619–628
Wang D, Wang T, Xu Z, Yu H, Feng B, Zhang J, Guo C, Yin Q, Zhang Z, Li Y. Small, 2016, 14: 488–498
Schroeder A, Heller DA, Winslow MM. Nat Rev Cancer, 2012, 12: 39–50
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feng, B., Zhou, F., Wang, D. et al. Gold nanomaterials for treatment of metastatic cancer. Sci. China Chem. 59, 984–990 (2016). https://doi.org/10.1007/s11426-016-5593-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-016-5593-0